The gut microbiota is increasingly recognized as a central regulator of energy balance and metabolic health in children
CoverWell: A Safety Net for Patients and Providers in Peptide/GLP-1 and Regenerative Therapies Modern regenerative medicinecovering GLP-1s, peptides, stem cells, and exosomes offers life-changing possibilities in weight loss, longevity, recovery, and performance optimization
Additionally, a multi-country study found substantial demand for GLP-1 medications among people without medical indications, highlighting the evolving landscape of body image and obesity treatment (Jensen et al., 2025)
Orders placed before 11 AM ship the same business day via Canada Post or courier
18% of US respondents reported taking prescription drugs for weight loss in 2025, up from 10% in 2024 Source: Euromonitors Voice of the Consumer: Health and Nutrition Survey, fielded February 2024 Legacy weight loss brands turn their attention towards GLP-1 consumers Heritage weight loss companies are shifting focus to accommodate the GLP-1 consumer
